Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Assays Compared For Diagnosis of Mycoplasma Infection

By LabMedica International staff writers
Posted on 23 Nov 2011
Both molecular and serological assays have been compared for detection of Mycoplasma infection in nasopharyngeal aspirates and serum samples.

Two commercial polymerase chain reaction (PCR) assays including a real-time PCR test, and an oligochromatographic test, and one serology test were compared for the ability to detect Mycoplasma pneumoniae mainly in pediatric patients.

At the Universitat Autònoma de Barcelona (Spain) a total of 145 nasopharyngeal aspirate specimens were collected from June 2008 to December 2009. More...
This included samples from pediatric patients with respiratory infection who presented at the emergency department and healthy children. Serum samples were obtained on admission, and convalescent serum samples were obtained 4–6 weeks later from all patients. Serum samples were tested on reception.

Serum samples were tested against M. pneumoniae using a commercial particle semiquantitative agglutination test kit (Serodia-Myco II test, Fujirebio; Tokyo, Japan, ). This agglutination assay uses gelatin particles sensitized with a crude antigen suspension of M. pneumoniae. The Speed-oligo M. pneumoniae test (Vircell; Granada, Spain) is a PCR-based method coupled to a dipstick device that enables a rapid detection of M. pneumoniae in clinical samples. The real-time PCR was performed with the SmartCycler II instrument (Cepheid; Sunnyvale, CA, USA).

Among the 145 samples, 32 serum pairs were serologically positive for M. pneumoniae. Of these, in 30 nasopharyngeal aspirates, M. pneumoniae was detected using the real-time PCR assay and 25 using Speed-oligo, corresponding to a sensitivity of 93.7% and 78.1%, respectively. Among the 94 samples with negative serology, only one positive result was obtained by real-time PCR assay. In the group of samples from healthy children, no positive results were obtained. M. pneumoniae is a pathogen that is a causative agent of respiratory tract infections

The authors concluded both PCR methods are fast; real-time PCR needs about one hour to complete and Speed-oligo PCR is completed within 55 minutes and detection requires no more than five minutes. However, the laboratory diagnosis of a chosen clinical episode should not rest on the PCR or acute phase serologic assay alone, but must also include antibody assays to confirm whether infection is current or represents persistence from past exposure. The study was published online on October 14, 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Universitat Autònoma de Barcelona
Fujirebio
Cepheid




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.